Dexmedetomidine inhibits the TNF-α and IL-6 at both the mRNA and protein levels.
α-Bungarotoxin reverses dexmedetomidine-induced decrease in NF-κBp65 activation.
α-Bungarotoxin reverses the protective effects of dexmedetomidine on septic mice.
Dexmedetomidine inhibits lung inflammatory through the cholinergic anti-inflammatory pathway.